Shanghai Pharma swallows Cardinal Health’s China unit The state-owned Chinese company enters new markets while US firm Cardinal Health retreats as new government rules spur consolidation. November 15, 2017
Shanghai Pharma targets Aussie vitamin maker The Chinese pharmaceutical firm offers $238 million to take Vitaco private, in the latest example of China’s huge interest in clean and green food products. August 04, 2016
China hungrier than ever for global assets China's outbound M&A activity reached a new record in the first half, putting it on track for a strong year, says PwC. August 15, 2011
Shanghai Pharma braves weak market with $2.2 billion IPO Shanghai Pharma's IPO beats the odds to find good demand in difficult market conditions. May 03, 2011